biotage, contact details, uppsala, sweden, charlottesville, USA

Interim report January - June 2010

Biotage AB (publ) - disclosure notice of substantial holding of shares

Biotage appoints Anders Wikström as Vice President of Operations and Anthony Rees as Chief Scientific Officer

Biotage Introduces Resolux™ Peptides Purification HPLC Columns

New Isolera™ UV-VIS Flash Purification System delivers widest wavelength range available to chemists (Copy)

Biotage Launches New Isolera™ ELS Detector, Helps Isolate Virtually Any Compound

Biotage Introduces Highly-Selective ExploraSep 96-Well Screening Plates based on Molecularly Imprinted Polymers

Biotage Introduces Highly-Selective AFFINILUTE MIP

European Peptide SymposiumBiotage are Gold Sponsors.
5th - 9th September
Copenhagen, DenmarkILMAC 201021st - 24th September
Basel, SwitzerlandAOACAugust 27-28
Orlando, FL27th Montreux Symposium on LC/MS 10th - 12th November
Montreux, SwitzerlandThe 3rd EBF Open Symposium 1st - 3rd December
Barcelona, Spain

Contact Details

Press and Investor Relations contacts:
Torben Jörgensen, President and CEO: Tel +46 (0)707 49 05 84
Mats-Olof Wallin, CFO: Tel +46 (0)18 56 59 12

Biotage AB Headquarters

Kungsgatan 76
SE-753 18 Uppsala, Sweden

Tel: +46 18 56 59 00
Fax: +46 18 59 19 22

info@biotage.com

Directions to Kungsgatan office

Sales Offices

Distributors

Technical Support

Biotage, LLC
10430 Harris Oaks Blvd., Suite C
Charlotte, NC 28269
U.S.A.
Telephone: +1 704 654 4900
Toll Free: +1 800 446 4752
Fax: +1 704 654 4917

info@biotage.com

Cardiff Manufacturing Site

Biotage GB Limited
Distribution Way
Dyffryn Business Park
Ystrad Mynach
Hengoed CF82 7TS
United Kingdom

info@biotage.com

Directions to Cardiff office

Print